Back to results
US 2013/0171666 A1Published application
Purinergic (P2X) Receptors in Extra-Cellular Body Fluid
AssigneeBiosceptre International Limited
InventorsAngus Gidley-Baird, Julian Alexander Barden
Life of this patent
Estimating the term…
Abstract
The invention relates to purinergic (P2X) receptors, to detection of protein in extra-cellular body fluids and to anti-bodies for the diagnosis or condition, especially cancer.
Claims5
1-22. (canceled)
A method for determining whether an individual has cancer, or is predisposed to cancer, including the steps of:
- providing a sample in the form of a tissue biopsy, the biopsy including extracellular spaces that have extracellular body fluid contained therein;
- applying the sample to a slide or support, thereby enabling fixing of protein in extracellular fluid in the extra-cellular spaces to the slide or support;
- contacting the sample with an anti-P2X7 receptor antibody or fragment thereof that binds a P2X7 receptor comprising SEQ ID NO:
- 2 in conditions for forming an immune complex between a P2X7 receptor, monomer or fragment thereof, in or derived from the extracellular body fluid in the sample and the antibody or fragment thereof;
- assessing the sample for the presence or absence of an immune complex in an extracellular space of the sample;
- and
- determining that the individual has cancer or is predisposed to cancer wherein the assessment reveals the presence of immune complex in extracellular space.
4 more elements
Dependencies are inferred from the claim text.